These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5045948)

  • 1. Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives.
    Stratigos JD; Bartsokas SK; Capetanakis J
    Br J Dermatol; 1972 Jun; 86(6):564-7. PubMed ID: 5045948
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of the cutaneous involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis with silver nitrate-impregnated dressings.
    Lehrer-Bell KA; Kirsner RS; Tallman PG; Kerdel FA
    Arch Dermatol; 1998 Jul; 134(7):877-9. PubMed ID: 9681360
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY; Pang SM; Thamotharampillai T
    J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed signals: toxic epidermal necrolysis.
    Villano JH; Lovell EO
    Am J Med; 2015 Mar; 128(3):254-6. PubMed ID: 25460525
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ; Heck JN
    J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol-induced toxic epidermal necrolysis.
    Dan M; Jedwab M; Peled M; Shibolet S
    Int J Dermatol; 1984 Mar; 23(2):142-4. PubMed ID: 6698688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal disease associated with toxic epidermal necrolysis (Lyell's disease).
    Krumlovsky FA; Del Greco F; Herdson PB; Lazar P
    Am J Med; 1974 Nov; 57(5):817-25. PubMed ID: 4440703
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular manifestations of toxic epidermal necrolysis associated with allopurinol use.
    Bennett TO; Sugar J; Sahgal S
    Arch Ophthalmol; 1977 Aug; 95(8):1362-4. PubMed ID: 889509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol and piroxicam.
    Xiong H; Liu G; Xiao J; Han Y; Liu T; Wan J; Yang J; Ding J; Dong X
    Eur J Dermatol; 2020 Oct; 30(5):620-621. PubMed ID: 33185537
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation.
    Watanabe Y; Matsukura S; Isoda Y; Morita A; Aihara M; Kambara T
    Acta Derm Venereol; 2013 Nov; 93(6):731-2. PubMed ID: 23604033
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.
    Auböck J; Fritsch P
    Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1969-70. PubMed ID: 3924329
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic epidermal necrolysis-case report and review of the literature.
    Ortiz JE; Horn MS; Peterson HD
    Ann Plast Surg; 1982 Sep; 9(3):249-53. PubMed ID: 7137822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive hypertrophic scarring after toxic epidermal necrolysis in a child.
    Kreft B; Lieser U; Haase R; Marsch WC; Wohlrab J
    Pediatr Dermatol; 2014; 31(4):527-8. PubMed ID: 23025572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

  • 19. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.